The Law Offices of Vincent Wong
SHAREHOLDER ALERT: FREQ RLX OCGN: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, NY / ACCESSWIRE / July 20, 2021 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Frequency Therapeutics, Inc. (NASDAQ:FREQ)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/frequency-therapeutics-inc-loss-submission-form?prid=17811&wire=1
Lead Plaintiff Deadline: August 2, 2021
Class Period: November 16, 2020 - March 22, 2021
Allegations against FREQ include that: the Company's Phase 2a trial results failed to live up to the Company's expectations as the results revealed no discernable difference between FX-322 and the placebo. In spite of the disappointing results, the Company continued to conduct the Phase 2a study while releasing positive statements in earnings calls, press releases, SEC filings, and pharmaceutical presentations about FX-322's potential. These statements materially misled the market and artificially inflated the value of Frequency's common stock.
RLX Technology Inc. (NYSE:RLX)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/rlx-technology-inc-loss-submission-form?prid=17811&wire=1
Lead Plaintiff Deadline: August 9, 2021
This lawsuit is on behalf of persons who purchased, or otherwise acquired, RLX American Depository Shares pursuant or traceable to the documents issued in connection with RLX's January 2021 initial public stock offering.
Allegations against RLX include that: the Company's then-existing exposure to China's ongoing campaign to establish a national standard for e-cigarettes, which would bring them into line with ordinary cigarette regulations, and that RLX's reported financials were not nearly as robust as the offering materials projected, nor were they indicative of future results. As a result, investors purchased RLX shares at artificially inflated prices.
Ocugen, Inc. (NASDAQ:OCGN)
If you suffered a loss, contact us at: https://www.wongesq.com/pslra-1/ocugen-inc-loss-submission-form?prid=17811&wire=1
Lead Plaintiff Deadline: August 17, 2021
Class Period: February 2, 2021 - June 10, 2021
Allegations against OCGN include that: (i) the information submitted to the U.S. Food and Drug Administration ("FDA") was insufficient to support an Emergency Use Authorization ("EUA"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
To learn more contact Vincent Wong, Esq. either via email email@example.com or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
KOMO Plant Based Foods Inc.3.8.2021 12:01:52 CEST | Press release
Komo Plant Based Foods Announces DTC Eligibility
FireFox Gold Corp3.8.2021 11:32:20 CEST | Press release
FireFox Reports Significant Gold from First-Ever Drilling at the Saittavaara Prospect, on the Jeesiö Project in Northern Finland
Achieve Life Sciences, Inc.3.8.2021 11:31:49 CEST | Press release
Achieve Life Sciences to Announce Second Quarter 2021 Financial Results and Host Conference Call and Webcast on August 12, 2021
Link Global Technologies Inc.3.8.2021 09:04:49 CEST | Press release
Link Global Technologies Enters into an $18 Million Equity Facility with Alumina Partners, LLC
Sanara MedTech Inc.2.8.2021 15:16:57 CEST | Press release
Sanara MedTech Inc. Announces Second Quarter 2021 Earnings Release and Conference Call Dates
Loop Industries, Inc.2.8.2021 15:03:06 CEST | Press release
Loop Industries and SK global chemical Close $56.5M Strategic Equity Deal, Provide Further Update on Asian Joint Venture to Manufacture 100% Recycled PET Plastic
Kingstone Companies, Inc2.8.2021 15:02:36 CEST | Press release
Kingstone Announces Estimated Prior Quarter Catastrophe Losses Kingstone Declares Quarterly Dividend of $0.04 per share
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom